Emerald Mutual Fund Advisers, Trust »

ImmunoGen shares owned by Emerald Mutual Fund Advisers, Trust

Quarter-by-quarter ownership of ImmunoGen shares owned by Emerald Mutual Fund Advisers, Trust from 13F filings

Historical chart of Emerald Mutual Fund Advisers, Trust investment in ImmunoGen

Tip: Access up to 7 years of quarterly data

All positions including ImmunoGen held by Emerald Mutual Fund Advisers, Trust consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in ImmunoGen by Emerald Mutual Fund Advisers, Trust

Quarter filed Position value Share count Share price at filing
2023-12-31 $35M 1.2M 29.65
2023-09-30 $23M 1.5M 15.87
2023-06-30 $15M 817k 18.87

More positions owned by Emerald Mutual Fund Advisers, Trust

ACADIA Pharmaceuticals (ACAD)
Carpenter Technology Corporation (CRS)
Freshpet (FRPT)
Varonis Sys (VRNS)
ImmunoGen
Churchill Downs (CHDN)
Blueprint Medicines (BPMC)
Super Micro Computer (SMCI)
Ftai Aviation (FTAI)
Transmedics Group (TMDX)
Tenable Hldgs (TENB)
Shift4 Payments Cl A Ord (FOUR)
Kratos Defense & Security Solutions (KTOS)
Chart Industries (GTLS)
Nv5 Holding (NVEE)

View all positions for Emerald Mutual Fund Advisers, Trust

Top funds holding ImmunoGen

Vanguard Group
RA Capital Management
Redmile Group
Henderson Group
Pentwater Capital Management
Fairmount Funds Management
Norges Bank Investment Management
Millennium Management
D. E. Shaw & Co
Balyasny Asset Management
Voloridge Investment Management
Boxer Capital
Maverick Capital
TIG Advisors
Tang Capital Management

View all funds holding ImmunoGen